net dbt
initi begin bear fruit
visibl acceler improv
quarter better organ sale growth acceler
cl report better expect organ sale growth acceler vs
develop emerg market y/i vs
respect ep vs growth balanc price volum
 america org sale acceler vs two-year stack
reflect promis earli result total sf e-commerc growth promo time
new elta/pca brand base price volum total price/oz
us overal still earli combin increas spend
new launch drove best org sale growth cl last year bode well
cl roll total sf hill initi amongst other cl maintain
fy outlook org sale gross margin though stop short reiter
previou target ep mid-singl digit behind higher ad spend
visibl target improv
cl saw solid organ sale growth hill y/i america lend
confid growth prospect cl two signific sale lever
also drive improv price/mix support cl sale
target latam acceler despit continu heavi promo brazil launch
non-colg brand like elmex pharma channel well receiv new total
roll apac remain challeng sale y/i sustain china
weak though cl expect result inflect mid-teen price come
recent launch gain traction market remain biggest nt
challeng view overal though cl solid start sale increas ad spend
even slightli short expect commod cost pressur deceler
promo comp eas leav ep estim unchang
reiter buy rais po
reiter buy rais po ep prior
justifi view cl improv growth prospect target
multipl cl would trade line histor level rel large-cap hpc peer
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
person household fabric pet nutrit
brand includ ajax fab softsoap palmol
mennen speed stick hill pet nutrit
colgate-palmol product market
cl heavi exposur develop market
command market share oral care posit
compani well outpac peer earn
cash flow result see cl one
attract long-term growth stori larg
impact result recent see subsid
expect growth acceler next
tabl detail perform region
tabl cl y/i result commentari segment
maintain market share leadership toothpast year date ytd maintain brand market leadership
us manual toothbrush ytd
oper margin pressur high raw materi cost higher overhead logist cost partial off-set fund
maintain market share leadership toothpast gain colombia dominican republ hondura uruguay
leadership manual toothbrush continu
oper margin pressur high raw materi cost higher overhead logist cost higher advertis
spend partial off-set fund growth save
maintain market share leadership toothpast gain unit kingdom itali switzerland denmark
oper margin pressur high raw materi cost higher advertis spend off-set fund growth save
lower overhead expens
maintain market share leadership toothpast gain philippin australia pakistan
oper margin pressur high raw materi cost higher overhead logist cost higher advertis
spend partial off-set fund growth save
maintain market share leadership toothpast gain turkey morocco saudi arabia lebanon jordan
oper margin pressur high raw materi cost higher advertis spend off-set fund growth
save lower overhead expens higher price
volum gain driven unit state western europ partial off-set declin south africa russia
oper margin pressur high raw materi cost higher advertis spend off-set fund growth
save lower overhead expens higher price
sale ep outlook unchang
cl maintain guidanc organ sale net sale flat low
singl digit lsd ep mid-singl digit -msd cl continu expect gross
profit advertis spend year though gross margin
reiter prior target instead simpli stick
abat balanc year
chang
chang
chang
chang
chang
chang
chang
flat lsd
higher
sale
sale
sale
ni non-controlling interest
ni non-controlling interest
mo end decemb
sale
sale
sale
depreci amort
ni attribut non-controlling inter
price object base forward price-to-earnings ep estim
premium large-cap stapl closer compani histor averag rel
market time cl gener best-in-class organ sale growth
demonstr abil manag difficult macro-economic/curr
environ recent result challeng organ sale improv
price ramp longer term see advantag countri categori exposur
risk downsid increas price competit stronger us macro
volatil particularli emerg market
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
